Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with moderate-to-severe plaque psoriasis
- People who are willing and able to sign a consent form allowing the trial site to verify their health information as required by local rules
- People who can read, understand, and fill in patient questionnaires in their local language, and are able to complete all required questionnaires throughout the trial
- People who have never previously been treated with a biological therapy, including the medication guselkumab (sometimes called "bio-naive")
- People whose doctor has decided to treat them with guselkumab for an approved medical reason
Who may not be able to join:
- People for whom guselkumab is medically unsuitable according to the most current approved prescribing information for this medication
- People who are pregnant or currently breastfeeding
- People who have taken part in another clinical trial involving an experimental treatment within the last 30 days before their first dose of guselkumab in this study
- People who are currently enrolled in another observational study that is sponsored or managed by a Johnson & Johnson company
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Johnson & Johnson Romania SRL Clinical Trial, Johnson & Johnson Romania SRL
Phone: 844-434-4210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to Guselkumab Discontinuation Throughout 2 Years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.